MedPath

Surgery Versus Internal Radiation in Treating Patients With Stage II Prostate Cancer

Phase 3
Completed
Conditions
Prostate Cancer
Registration Number
NCT00023686
Lead Sponsor
Alliance for Clinical Trials in Oncology
Brief Summary

RATIONALE: Internal radiation uses radioactive material placed directly into or near a tumor to kill tumor cells. It is not yet known whether surgery is more effective than internal radiation in treating prostate cancer.

PURPOSE: Randomized phase III trial to compare the effectiveness of surgery with that of internal radiation in treating patients who have stage II prostate cancer.

Detailed Description

OBJECTIVES:

* Compare overall survival in patients with stage II prostate cancer treated with radical prostatectomy vs brachytherapy.

* Compare metastasis-free survival and probability of survival without symptoms of patients treated with these regimens.

* Compare the side effects of these treatment regimens in these patients.

OUTLINE: This is a randomized study. Patients are randomized to one of two treatment arms.

* Arm I: Patients undergo radical prostatectomy.

* Arm II: Patients undergo brachytherapy with implanted iodine I 125 or palladium Pd 103 seeds Patients are followed every 6 months for 5 years and then annually thereafter.

PROJECTED ACCRUAL: A total of 1,980 patients (990 per treatment arm) will be accrued for this study within 5.5 years.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
190
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
overall survivalUp to 10 years
Secondary Outcome Measures
NameTimeMethod
disease free survivalUp to 10 years

Trial Locations

Locations (36)

St. Vincent Cancer Center

πŸ‡ΊπŸ‡Έ

Little Rock, Arkansas, United States

UCSF Comprehensive Cancer Center

πŸ‡ΊπŸ‡Έ

San Francisco, California, United States

Walter Reed Army Medical Center

πŸ‡ΊπŸ‡Έ

Washington, District of Columbia, United States

H. Lee Moffitt Cancer Center and Research Institute

πŸ‡ΊπŸ‡Έ

Tampa, Florida, United States

Winship Cancer Institute of Emory University

πŸ‡ΊπŸ‡Έ

Atlanta, Georgia, United States

Southern Illinois University School of Medicine

πŸ‡ΊπŸ‡Έ

Springfield, Illinois, United States

Holden Comprehensive Cancer Center at University of Iowa

πŸ‡ΊπŸ‡Έ

Iowa City, Iowa, United States

Kansas Cancer Institute at the University of Kansas Medical Center

πŸ‡ΊπŸ‡Έ

Kansas City, Kansas, United States

Beth Israel Deaconess Medical Center

πŸ‡ΊπŸ‡Έ

Boston, Massachusetts, United States

Washington University School of Medicine

πŸ‡ΊπŸ‡Έ

Saint Louis, Missouri, United States

Scroll for more (26 remaining)
St. Vincent Cancer Center
πŸ‡ΊπŸ‡ΈLittle Rock, Arkansas, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.